Stock Events

Stock Events

Candel Therapeutics (CADL) Q1 2025 Earnings

13MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.74

-0.57

-0.4

-0.23

Details

Expected EPS

-0.227612

Actual EPS

-0.4

Surprise EPS

-0.17

Surprise Percent

+75.74%

Description

Candel Therapeutics (CADL) has reported earnings of -0.4 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.